Medicare billing address
CMS Medicare provider billing file
852 N 9Th StStroudsburg, PA 18360
CMS public data · NPI 1255319646
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Thomas P Kislan, O.D.
Specialty
Credential
O.D.
NPI
1255319646
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Thomas P Kislan, O.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
852 N 9Th StCMS Doctors & Clinicians file
281 Airport RdCMS Doctors & Clinicians file
2942 Route 611In the 2024 CMS provider billing file, this NPI had 551 Medicare beneficiaries and 11,486 total services. The average beneficiary age was 76, and the average HCC risk score was 1.1.
Total Medicare allowed amount
$945,694.53
Total Medicare payment amount
$733,473.87
Medicare beneficiaries
551
Total services
11,486
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
33%
CMS beneficiary-panel share
Chronic kidney disease
30%
CMS beneficiary-panel share
Ischemic heart disease
29%
CMS beneficiary-panel share
Anxiety
22%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 2,962 | $144.32 |
| Microfluid analysis of tears | 1,477 | $22.03 |
| Analysis of substance using immunoassay technique, multiple step method | 1,476 | $11.30 |
| Photography of the retina | 1,069 | $31.98 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,065 | $113.46 |
| Imaging of retina | 715 | $35.00 |
| Measurement of retinal and optic nerve function | 696 | $107.81 |
| Insertion of drug delivery implant into tear duct of eye | 380 | $35.88 |
| Extended exam involving color vision testing | 313 | $38.73 |
| Closure of tear duct opening using plug | 299 | $168.15 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1255319646. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Restasis | Cyclosporine | 232 | 525 | $316,961.89 |
| 2 | Lumigan | Bimatoprost | 187 | 442.2 | $111,999.54 |
| 3 | Lotemax Sm | Loteprednol Etabonate | 100 | 139.5 | $36,184.68 |
| 4 | Miebo | Perfluorohexyloctane/Pf | 93 | 106.8 | $77,328.90 |
| 5 | Cyclosporine | Cyclosporine | 78 | 182 | $55,828.08 |
| 6 | Combigan | Brimonidine Tartrate/Timolol | 77 | 117 | $25,487.01 |
| 7 | Xiidra | Lifitegrast | 76 | 154 | $103,297.08 |
| 8 | Cequa | Cyclosporine | 61 | 129 | $72,362.19 |
| 9 | Latanoprost | Latanoprost | 53 | 129.7 | $887.11 |
| 10 | Vyzulta | Latanoprostene Bunod | 50 | 57.9 | $14,585.70 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Pennsylvania College Of Optometry
Graduation year
1996
Group/practice field
Dr Sandra M Krokos And Thomas P Kislan Pc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.